title: [Vasopeptidase inhibitors. Clinical implications of a new class of drugs].
authors.affiliation: Abteilungen für Kardiologie und Kardiovaskuläre Forschung, Universitätsspital Zürich, Schweiz.
authors.forename: T
authors.initials: T
authors.lastname: Quaschning
authors.forename: R
authors.initials: R
authors.lastname: Corti
authors.forename: F T
authors.initials: FT
authors.lastname: Ruschitzka
authors.forename: G
authors.initials: G
authors.lastname: Noll
authors.forename: T F
authors.initials: TF
authors.lastname: Lüscher
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D009320:Atrial Natriuretic Factor / Q000097:blood; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D004195:Disease Models, Animal; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D015260:Neprilysin / Q000037:antagonists & inhibitors*; D012084:Renin-Angiotensin System / Q000187:drug effects
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D009320:Atrial Natriuretic Factor; D015260:Neprilysin